top of page
Expansion Rx News:
Site Under Construction
Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
Mar 2, 2023
2,755
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
Oct 26, 2022
1,381
Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 24, 2022 --...
Jan 24, 2022
1,076
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to its Board of Directors
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 19, 2022 -- Expansion...
Jan 19, 2022
670
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
-- Funding to advance the company’s SMiRNA™ platform to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyotrophic...
Sep 29, 2021
4,984
Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
Jun 14, 2021
567
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research...
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research
May 25, 2021
936
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
May 6, 2021
560
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President
Meet Expansion Therapeutics New CEO
Oct 5, 2020
648
bottom of page